Objective: There have been prominent changes in evaluation of resistance patterns of pneumococci and breakpoint values in recent years. We aimed to investigate the penicillin sensitivity of pneumococcal strains isolated from the cerebrospinal fluid specimens between the years 1997-2011 in our hospital and determine the MIC values under the light of these changes.
INTRODUCTION
Streptococcus pneumoniae which was first described in 1880, is still an important cause of mortality and morbidity globally. Pneumococcal meningitis is a severe form of meningitis with devastating sequela and frequent recurrences, as well as being a high-risk disease particularly for patients with diabetes or other diseases that weaken the immune system, with a mortality that is nearly equal to that in the pre-antibiotic era. 1 Although introduction of penicillin into clinical practice opened a new epoch in the treatment of diseases caused by S. pneumoniae, the first resistant isolate was reported in 1967, and other reports of resistant strains followed this from all around the world.
2 Until 1980, this resistance was both rare and moderate without clinical failure in penicillin treatment. The epidemics in 1980s with resistant S. pneumoniae strains and high-levels of resistance with clinical treatment failures brought this issue into the light once again. Especially the high levels of resistance detected in some regions of the world have brought attentions to these severe, life-threatening infections. Great changes have occurred in resistance patterns of pneumococci and break point values in recent years. MIC values of S. pneumoniae strains isolated from the cerebrospinal fluid (CSF) in the last 15 years were evaluated according to new criteria in the present study. MIC range for penicillin was determined as 0.016-0.75 μg/ml (Table 1) . Eight strains were resistant to penicillin (14%) and 44 strains (77.1%) were sensitive ( Figure 1 ). Five strains (8.7%) were between the ranges for sensitive and resistant. The first resistant strain was isolated in the year 2000. A MIC90 value of 0.19 μg/ml was found and a MIC50 value of 0,016 μg/ml was detected in all isolates. When examined over the years increased resistance was 5.3% in the first five-year period seems to be 28.6% in the last five-year period ( Figure 2 ). 
METHODS

DISCUSSION
The sole natural reservoir of S. pneumoniae is the human nasopharynx. All children become colonized by one or more strains in the first year of their lives and thus become carriers. It is reported that 50% of two-month old infants are colonized in South India, and 30% of six-month old infants are carriers in South Africa. 4 Penicillin resistance of S. pneumoniae is a resistance caused by a change in the structure of penicillin-binding proteins. In 2008, the samples used in the evaluation were classified as meningitis isolates and nonmeningitis isolates, and a value of ≤0.06 μg/ml was used for susceptible, and ≥0.12 μg/ml resistance for meningitis isolates, while for nonmeningitis isolates, ≤2 μg/ml was susceptible, 4 μg/ml intermediate and ≥8 μg/ml resistant. 3 According to this new standardization, frequency of penicillin resistance in pneumococci in infections other than meningitis will decrease, whereas resistance in CSF samples will increase. When we evaluate the samples in our study according to the CLSI criteria before 2008, there is no resistant strain. The resistant strains, which consist 14% according to new criteria were formerly in the intermediate group. With this new approach, penicillin use will increase in respiratory system infections and as a result, the frequency of bacteria such as resistant pneumococci, MRSA and C. difficile may decrease. Especially regional spread of high level resistance should be carefully monitored and the first choice in the treatment should be penicillin G in the absence of special indications. The result of resistance due to a change in PBPs of S. pneumoniae is an increase in penicillin MIC values, with a parallel increase in MIC values of other β-lactam antibiotics, which cause further decrease in our treatment options.
In a multicenter study in Turkey, 72 pneumococcal strains were isolated from the CSF in a period of five years, and high level resistance to penicillin G was not detected with E test, while intermediate susceptibility was detected in six strains (8.3%). The rate of resistance was lower than the rate we determined in the present study. 6 In the study by Tuncer et al., with 89 pneumococcal strains isolated from various clinical samples (16 from CSF), high level resistance to penicillin was detected in 4%, and intermediate susceptibility in 15%. 7 In a multicenter study from Istanbul and Adana city with 93 strains causing invasive pneumococcal disease (19 CSF samples) isolated between 2001-2004, intermediate susceptibility was detected in 31% and resistance in 8%. 8 In a study from Turkey, 182 invasive pneumococcal isolates (32 and 150 isolates from cerebrospinal fluid and blood samples, respectively) were collected before the introduction of the 7-valent pneumococcal conjugate vaccine. In total, 50% CSF isolates were resistant to penicillin (MIC ≥0.12 μg/l) according to 2012 CLSI guidelines. Intermediate resistance was not observed. This rate of resistance was approximately three fold higher than the rate of present study. 9 In a surveillance study of children in Kenya, Uganda, Tanzania and Ethiopia, a total of 442 pneumococcal strains, 302 from blood and 140 from CSF were isolated and no penicillin resistance was detected in any strains. 10 In a surveillance program from Canada between the years 1991-1998, 1847 pneumococcal strains were studied (275 from CSF) and a statistically significant increase in resistance was found. Intermediate level resistance was detected as 8.4%, high level resistance 1.1%, and reduced susceptibility 9.5% in strains which had caused meningitis. 11 In a study from Nepal in 2528 children with suspected invasive bacterial disease, meningitis were detected in 9.6% and 33 cases were designated as pneumococcal meningitis. 4% of all invasive isolates were penicillin resistant and intermediate susceptibility was detected in only one CSF isolate (MIC 0.5 μg/ml). 12 In a study with Korean children between the years 1985-1996, 106 invasive pneumococcal infections (19% meningitis), were evaluated and the first penicillin-resistant pneumococcal strain was isolated in 1989. Resistance rates have shown a steady increase and reached 89% in 1996. Penicillin resistance was found in 45% of 20 cases with meningitis. 13 High rates of resistance (71.5%) was reported by PROTEKT study from South Korea. 14 The pneumococcal resistance rates in our study is considerably lower than those reported by these studies.
In a sensitivity study of 11 years' duration on invasive pneumococcal strains from Portugal, the ratio of strains which were not sensitive to penicillin was 12% in 1994, increasing to 23.2% in 2004. Strains from CSF samples with intermediate and high level resistance was 16.2%, 2.9%, respectively in 1994 and 18.8%, 1.3% respectively in 2004. 15 Analyzing the 72 invasive pneumococcal strains obtained from patients with meningitis during the years 1999 and 2009 in Brazil, the penicillin resistance rates for all ages was 23.6% and for children up to two years of age 39.4%. Significant increases in the penicillin-resistance rates of invasive pneumococcal strains have been reported in Brazil. 16 Pneumococcal infections, which may be seen in every age group, may result in severe sequel or death due to treatment failures caused by bacterial resistance, especially if they occur in life-threatening locations. Thus, knowledge on pneumococcal resistance patterns enables initiation of an appropriate treatment.
This study has some limitations. One of these limitations is absence of the determination of serotypes. The other limitation is the number of the strain was not high. Beside these limitations, this study will contribute new information about pneumococci resistance.
In conclusion, the new penicillin susceptibility breakpoints have increased the resistance rates in meningitis invasive pneumococcal infections. Penicillin therapy may be fail in meningitis if the rate of resistant isolates is high. The need for pneumococcal surveillance studies continues.
